SOURCE: Wall Street Equity Research

Wall Street Equity Research

November 23, 2010 08:36 ET

Analyst Study on Walgreen Co. and CVS Caremark Corporation - Drug Stores Up 3Q Lobbying Efforts

JOHANNESBURG, SOUTH AFRICA--(Marketwire - November 23, 2010) - brings investors market knowledge on the aspects moving the drug stores stocks, and offers complete analytical research on companies like Walgreen Co. (NYSE: WAG) and CVS Caremark Corporation (NYSE: CVS). Register with today to gain full access to our complimentary research on these drug stores stocks.

Two of the country's top 3 drug stores increased their lobbying efforts in the third quarter to offset a variety of rising industry related costs. Visit us at to understand the catalysts and forces driving or affecting companies in the drug stores industry. is a specialized website where investors can have specific access to complimentary reports on drug stores industry; traders looking for analysis on Walgreen Co., CVS Caremark Corporation and other players in the industry are welcomed to sign up for free at

A lot of the spending has been aimed at the healthcare reform bill that has adversely affected revenues for drug stores such as Walgreen Co. in certain areas. It is important to note that the reform bill has improved revenues for drug companies in some areas as well. The majority of the cost increases as a result of the bill have stemmed from compliance related spending. Investors can register today at to download the full report on Walgreen Co.

CVS Caremark Corporation upped its lobbying spending to try get a law passed that would require the U.S. Postal Service to have 12 non-mailing days a year. The 12 non-mailing days would help drug stores cut costs as well as improve security and drug disposal procedures. Investors can access free research on CVS Caremark Corporation now by signing up at

At this point, the results of the increased lobbying spending are yet to be seen. Successful efforts could result in amendments to the healthcare reform bill and the passage of a U.S. Postal service law, both of which could provide substantial savings to the drug store industry. 

About Wall Street Equity Research: 
Wall Street Equity Research looks to bring simplicity and highly sophisticated research to an ever-changing investing environment. Wall Street Equity Research has been partnering with a number of North American and Emerging Economies analysts to bring you the best of both continents in terms of market analysis and analytical opinions. 

Contact Information